The Journal of Hip Surgery 2017; 01(01): 022-026
DOI: 10.1055/s-0036-1597959
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Total Hip Arthroplasty Procedure Frequencies in Patients with Osteonecrosis versus Osteoarthritis

Anton Khlopas
1   Department of Orthopaedic Surgery, Cleveland Clinic Foundation, Cleveland, Ohio, United States
,
Morad Chughtai
1   Department of Orthopaedic Surgery, Cleveland Clinic Foundation, Cleveland, Ohio, United States
,
Jared M. Newman
1   Department of Orthopaedic Surgery, Cleveland Clinic Foundation, Cleveland, Ohio, United States
,
Prem N. Ramkumar
1   Department of Orthopaedic Surgery, Cleveland Clinic Foundation, Cleveland, Ohio, United States
,
Sergio M. Navarro
2   Department of Orthopaedic Surgery, Baylor College of Medicine, Houston, Texas, United States
,
Lynne C. Jones
3   Department of Orthopaedic Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
,
Steven F. Harwin
4   Department of Orthopaedic Surgery, Mount Sinai Health System, New York, New York, United States
,
Michael A. Mont
1   Department of Orthopaedic Surgery, Cleveland Clinic Foundation, Cleveland, Ohio, United States
› Author Affiliations
Further Information

Publication History

Publication Date:
31 March 2017 (online)

Abstract

Atraumatic osteonecrosis (ON) of the hip is a debilitating disease. Multiple surgical treatment options are available ranging from joint-preserving procedures to total hip arthroplasty (THA), which is the most commonly performed treatment not only for ON but also for osteoarthritis (OA). Multiple studies have described the rates and trends of THA for OA and ON; however, none have directly compared the two. Therefore, the purpose of this study was to (1) determine the frequency and trends of joint replacement procedures; (2) compare these findings between the ON and OA populations; and (3) assess trends for revision total hip arthroplasty (rTHA). The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) database was evaluated for this study. All patients in this database obtained between 2008 and 2014 who had a diagnosis of hip ON or OA were identified using International Classification of Disease, 9th revision codes for hip ON and OA. This yielded 68,434 patients, including 3,816 patients with ON (mean age: 55 years, range: 18–90 years) and 64,618 patients with OA (mean age: 65 years, range: 18–90). The Cochran-Armitage test for trends was used to assess the differences in THA and rTHA rates over the study time period for each cohort. To compare whether these rates were different between ON and OA patients, we performed a Z-test between the groups for each year. The annual number of primary THA performed increased for both ON and OA between 2008 and 2014 (from 62 to 989 and from 1,011 to 19,004, respectively). The rate of primary THA significantly increased from 69 to 88% in ON patients. The rate of THAs for ON, out of all THAs performed for both ON and OA, decreased from 5.8% in 2008 to 4.9% in 2014. . The rate of rTHAs performed for both ON and OA decreased during this time (1.1–0.4% for ON and 0.4–0.2% for OA). ON patients had a significantly higher rate of rTHA only in 2011 and a higher rate of overall revisions. The rate of THA is increasing for both ON and OA, but the slope of the increase is higher for ON. This may indicate that orthopaedic surgeons are more confident in performing THA as newer devices and designs are being developed, allowing for better survivorship and outcomes. Additionally, although the overall rate of revision was higher in the ON cohort, at most annual time points, there was no significant difference. Further research is needed to determine why such trends exist.

 
  • References

  • 1 Mont MA, Hungerford DS. Non-traumatic avascular necrosis of the femoral head. J Bone Joint Surg Am 1995; 77 (3) 459-474
  • 2 Nam KW, Kim YL, Yoo JJ, Koo K-H, Yoon KS, Kim HJ. Fate of untreated asymptomatic osteonecrosis of the femoral head. J Bone Joint Surg Am 2008; 90 (3) 477-484
  • 3 Min B-W, Song K-S, Cho C-H, Lee S-M, Lee K-J. Untreated asymptomatic hips in patients with osteonecrosis of the femoral head. Clin Orthop Relat Res 2008; 466 (5) 1087-1092
  • 4 Zalavras CG, Lieberman JR. Osteonecrosis of the femoral head: evaluation and treatment. J Am Acad Orthop Surg 2014; 22 (7) 455-464
  • 5 Banerjee S, Issa K, Pivec R, Kapadia BH, Khanuja HS, Mont MA. Osteonecrosis of the hip: treatment options and outcomes. Orthop Clin North Am 2013; 44 (4) 463-476
  • 6 Johnson AJ, Mont MA, Tsao AK, Jones LC. Treatment of femoral head osteonecrosis in the United States: 16-year analysis of the Nationwide Inpatient Sample. Clin Orthop Relat Res 2014; 472 (2) 617-623
  • 7 Kurtz SM, Lau E, Ong K, Zhao K, Kelly M, Bozic KJ. Future young patient demand for primary and revision joint replacement: national projections from 2010 to 2030. Clin Orthop Relat Res 2009; 467 (10) 2606-2612
  • 8 Bozic KJ, Kurtz SM, Lau E, Ong K, Vail TP, Berry DJ. The epidemiology of revision total hip arthroplasty in the United States. J Bone Joint Surg Am 2009; 91 (1) 128-133
  • 9 Kurtz SM, Ong KL, Schmier J, Zhao K, Mowat F, Lau E. Primary and revision arthroplasty surgery caseloads in the United States from 1990 to 2004. J Arthroplasty 2009; 24 (2) 195-203
  • 10 NSQIP. American College of Surgeons National Surgical Quality Improvement Program. n.d. https://www.facs.org/quality-programs/acs-nsqip? . Accessed August 11, 2016
  • 11 Hall BL, Hamilton BH, Richards K, Bilimoria KY, Cohen ME, Ko CY. Does surgical quality improve in the American College of Surgeons National Surgical Quality Improvement Program: an evaluation of all participating hospitals. Ann Surg 2009; 250 (3) 363-376
  • 12 Khuri SF, Daley J, Henderson W , et al; National VA Surgical Quality Improvement Program. The Department of Veterans Affairs' NSQIP: the first national, validated, outcome-based, risk-adjusted, and peer-controlled program for the measurement and enhancement of the quality of surgical care. Ann Surg 1998; 228 (4) 491-507
  • 13 Shiloach M, Frencher Jr SK, Steeger JE , et al. Toward robust information: data quality and inter-rater reliability in the American College of Surgeons National Surgical Quality Improvement Program. J Am Coll Surg 2010; 210 (1) 6-16
  • 14 Drager J, Hart A, Khalil JA, Zukor DJ, Bergeron SG, Antoniou J. Shorter hospital stay and lower 30-day readmission after unicondylar knee arthroplasty compared to total knee arthroplasty. J Arthroplasty 2016; 31 (2) 356-361
  • 15 Lieberman JR, Berry DJ, Mont MA , et al. Osteonecrosis of the hip: management in the 21st century. Instr Course Lect 2003; 52: 337-355
  • 16 McGrory BJ, York SC, Iorio R , et al. Current practices of AAHKS members in the treatment of adult osteonecrosis of the femoral head. J Bone Joint Surg Am 2007; 89 (6) 1194-1204
  • 17 Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 2007; 89 (4) 780-785
  • 18 Mont MA, Jones LC, Sotereanos DG, Amstutz HC, Hungerford DS. Understanding and treating osteonecrosis of the femoral head. Instr Course Lect 2000; 49: 169-185
  • 19 Kim S-M, Lim S-J, Moon Y-W, Kim Y-T, Ko K-R, Park Y-S. Cementless modular total hip arthroplasty in patients younger than fifty with femoral head osteonecrosis: minimum fifteen-year follow-up. J Arthroplasty 2013; 28 (3) 504-509
  • 20 Stavrakis AI, SooHoo NF, Lieberman JR. A comparison of the incidence of complications following total hip arthroplasty in patients with or without osteonecrosis. J Arthroplasty 2015; 30 (1) 114-117
  • 21 Issa K, Pivec R, Kapadia BH, Banerjee S, Mont MA. Osteonecrosis of the femoral head: the total hip replacement solution. Bone Joint J 2013; 95-B (11, Suppl A): 46-50
  • 22 Bedard NA, Callaghan JJ, Liu SS, Greiner JJ, Klaassen AL, Johnston RC. Cementless THA for the treatment of osteonecrosis at 10-year follow-up: have we improved compared to cemented THA?. J Arthroplasty 2013; 28 (7) 1192-1199
  • 23 Lavernia CJ, Villa JM. Total hip arthroplasty in the treatment of osteonecrosis of the femoral head: then and now. Curr Rev Musculoskelet Med 2015; 8 (3) 260-264